Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02978846 · ClinicalTrials.gov registry record
Perceptions of Side Effects of Cancer Chemoradiotherapy
A clinical trial, sponsored by University of Southern California.
- Completed
- Registry status
- 62
- Enrollment target
NCT02978846: Completed study, sponsored by University of Southern California.
NCT02978846 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02978846 has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
Study Summary
This study is asking patients who are undergoing radiation therapy with or without chemotherapy on how well they evaluate their side effects on the last day of treatment. This study is not to change health outcomes of the patients in this study. Asking patients to rank side effects in order of which ones bother them the most may help researchers identify the most troubling side effects of cancer treatment.
Primary Outcome
Tables and bar charts will be used to display the 10-20 highest ranked side effects overall, by sex and concurrent chemotherapy. Descriptive statistics such as means and standard deviation will be used.
Interventions
- OTHER Clinical Observation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2016-06-01 |
| Est. Completion | 2018-08-14 |
What the finished NCT02978846 record still lists
NCT02978846 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 62 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Clinical Observation is the first listed.
NCT02978846 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02978846 about?
NCT02978846 is a clinical study titled "Perceptions of Side Effects of Cancer Chemoradiotherapy". This study is asking patients who are undergoing radiation therapy with or without chemotherapy on how well they evaluate their side effects on the last day of treatment. This study is not to change health outcomes of the patients in this study. Asking patients to rank side effects in order of which...
What is the current status of trial NCT02978846?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2016-06-01. Estimated completion is 2018-08-14.
What interventions are being tested in trial NCT02978846?
The interventions under investigation include: Clinical Observation (OTHER).
Who is sponsoring clinical trial NCT02978846?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI